Organisation
Statens Serum Institut (SSI) consists of a management board, three health priority areas and staff units – all with their own departments.
See the organisation chart as a pdf.
Management board
Mads Melbye (President & CEO)
Ole Jensen (Executive Vice President)
Helle Birk Krogsgaard (Chief Financial Officer)
Supported by Executive Vice Presidents for:
- Infectious Disease Preparedness (Kåre Mølbak, Executive Vice President)
- Danish National Biobank & Biomarkers(Helle B. Konradsen, Executive Vice President)
- Research - vaccines (Peter L. Andersen, Executive Vice President)
Organisation
Corporate Affairs
Center for Biosecurity & Biopreparedness
Business Support & Campus (Helle Birk Krogsgaard, Chief Financial Officer)
Finance
Campus
Supply
Business Development
Infectious Disease Preparedness (Kåre Mølbak, Executive Vice President)
Infectious Disease Preparedness
Infectious Disease Epidemiology & Prevention
Bacteria, Parasites & Fungi
Virus & Microbiological Special Diagnostics
International Reference Laboratory of Mycobacteriology
Danish National Biobank & Biomarkers (Helle B. Konradsen, Executive Vice President)
Danish National Biobank & Biomarkers
Congenital Disorders
Danish National Biobank
Prediagnostics & Service
Research - vaccines (Peter L. Andersen, Executive Vice President)
Infectious Disease Immunology
Vaccine Development
QA/QC
Research - epidemiology (Mads Melbye, President & CEO, Executive Vice President)
Epidemiology research
Bandim Health Project